Results 141 to 150 of about 16,522 (224)

Cryoablation as an organ-preserving therapy for low rectal cancer a comprehensive protocol and institutional perspective. [PDF]

Front Oncol
Jiang X, Zhou F, Ji Z, Lei X, Yuan F.
europepmc   +1 more source

Tolerability of breast radiotherapy following cryoablation in the local management or palliation of breast cancer: a case series. [PDF]

Ann Med Surg (Lond)
Taghian GN, Bryce Y, Braunstein LZ.
europepmc   +1 more source

Pre-Spondylectomy Radiofrequency Ablation for Spinal Chordoma: An Illustrative Case and Systematic Review of Clinical Applications and Outcomes. [PDF]

Curr Oncol
Husbands H, Johnston D, Tharakan M, Hussan A, Balasubramanian K, Bettiol P, Chou B, Hameed S, Smith ZA, Janjua MB, Burke JF, Shakir HJ.   +11 more
europepmc   +1 more source

Awakening antitumour immunity in the multimorbid host: a hypothesis coupling cryoablation-induced immunogenic cell death with multi-target Traditional Chinese Medicine. [PDF]

Front Immunol
Liu L, Chen H, Wang J, Yang J, Zhou Y, Luo B, Zhou Y, Hu K.   +7 more
europepmc   +1 more source

Curative-Intent Cryoablation for Bone Metastases: Study Protocol for BOREALIS, a Prospective Multicentre Observational Investigation. [PDF]

Cardiovasc Intervent Radiol
Cazzato RL, Buy X, Gomez F, Deschamps F, Arnold D, Filippiadis D, Jennings J, Schaefer N, Schneegans O, Tsoumakidou G, Zeka B, Poulet C, Kaufmann N, Palussiere J, Gangi A.   +14 more
europepmc   +1 more source

Synergistic cryoablation and immunotherapy in the treatment of metastatic melanoma of unknown primary. [PDF]

JAAD Case Rep
Adil A, Liu W, Levy A, Krunic A.
europepmc   +1 more source

The tumor microenvironment in triple negative breast cancer and a strategy to improve responses to immunotherapy using cryoablation and immunostimulants. [PDF]

Cancer Biol Ther
Illindala R, Yang Y, Mandt T, Webster N, Steinmetz N, Newton I.   +5 more
europepmc   +1 more source

Efficacy and Safety of Co-Ablation Combined With Aintilimab for Metastatic Melanoma to the Liver (CryoCheck-001): A Phase II Trial. [PDF]

MedComm (2020)
Shen L, Lin L, Chen S, Li C, Tang R, Xie L, Wang Y, Li Y, Zou H, Li D, Zhang X, Fan W.   +11 more
europepmc   +1 more source